Zealand Pharma's short bowel syndrome drug wins backing from EU panel

Zealand Pharma received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending approval of Zeydovio for short bowel syndrome. The recommendation is a significant regulatory milestone and improves the likelihood of eventual European commercialization for the drug candidate.